Insulin Detemir (Levemir) from Japan
Soluble long-acting insulin analogue with fatty acid modification for albumin binding. HTS 2937.12.00.00 applies to this rDNA-produced derivative used primarily as a basal insulin hormone replacement.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• FDA import alert 66-40 applies; pre-clearance with biologics license holder required
• Maintain 2-8°C throughout supply chain with calibrated data loggers
• Declare as 'pure insulin analogue substance' not 'medicament' for correct heading